Concepedia

Sai Prasad

SP

Statistics

Publications

20

Citations

2.3K

H-Index

17

Active since

2014

Affiliations

Bharat Biotech (India)(Current)

ICMR-National Institute of Virology

Indian Council of Medical Research

All India Institute of Medical Sciences

Nizam's Institute of Medical Sciences

Sai Prasad is an author at Bharat Biotech (India) specializing in vaccinology, vaccination, and infectious diseases.

ORCID

Publications per year

2014–2023

20

Publications

20

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial

Raches Ella, Krishna Mohan Vadrevu, Harsh Jogdand et al. · The Lancet Infectious Diseases · 2021 · 438 citations · Full text

, , +12

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial

Raches Ella, Siddharth Reddy, Harsh Jogdand et al. · The Lancet Infectious Diseases · 2021 · 365 citations · Full text

, , +17

Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial

Raches Ella, Siddarth Reddy, William C. Blackwelder et al. · The Lancet · 2021 · 362 citations · Full text

, , +12

Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial

Nita Bhandari, Temsunaro Rongsen‐Chandola, Ashish Bavdekar et al. · The Lancet · 2014 · 327 citations

, , +15

Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life

Nita Bhandari, Temsunaro Rongsen‐Chandola, Ashish Bavdekar et al. · Vaccine · 2014 · 102 citations · Full text

, , +17

1–5 of 20